Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $3.5
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley has maintained its Underweight rating on PetMed Express (NASDAQ:PETS) and lowered the price target from $6.5 to $3.5.

June 12, 2024 | 11:56 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Morgan Stanley has maintained its Underweight rating on PetMed Express and significantly lowered the price target from $6.5 to $3.5, indicating a bearish outlook.
The Underweight rating and significant reduction in price target from $6.5 to $3.5 by Morgan Stanley suggest a negative outlook for PetMed Express. This is likely to result in a short-term decline in the stock price as investors react to the bearish sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100